GAMMA Investing’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.2K Sell
1,605
-39
-2% -$732 ﹤0.01% 2776
2026
Q2
$24.8K Sell
1,644
-1,858
-53% -$32.4K ﹤0.01% 2723
2026
Q1
$67.1K Sell
3,502
-1,040
-23% -$22.6K ﹤0.01% 1964
2025
Q4
$99.8K Buy
4,542
+3,429
+308% +$61.9K 0.01% 1580
2025
Q3
$13.5K Sell
1,113
-508
-31% -$6.88K ﹤0.01% 2717
2025
Q2
$30.2K Sell
1,621
-581
-26% -$11.5K ﹤0.01% 2245
2025
Q1
$42.2K Sell
2,202
-2,685
-55% -$78.6K ﹤0.01% 1915
2024
Q4
$176K Sell
4,887
-118
-2% -$3.99K 0.02% 762
2024
Q3
$212K Buy
5,005
+729
+17% +$30.9K 0.02% 597
2024
Q2
$172K Buy
4,276
+431
+11% +$18K 0.02% 551
2024
Q1
$136K Buy
3,845
+1,375
+56% +$36.8K 0.03% 528
2023
Q4
$56.3K Buy
+2,470
New +$51.2K 0.02% 828

Other funds holding TNDM

GAMMA Investing's TNDM Position: Q3 2026 in Review

GAMMA Investing reduced its Tandem Diabetes Care (TNDM) stake by 2.4% in Q3 2026, selling an estimated $732 and leaving 1,605 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

GAMMA Investing first reported a position in TNDM in Q4 2023 and has held it in 12 quarters since. The position peaked at $212K in Q3 2024. 9 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • GAMMA Investing held 1,605 shares of Tandem Diabetes Care worth $26.2K as of Q3 2026.
  • GAMMA Investing sold 39 Tandem Diabetes Care shares in Q3 2026, an estimated $732.
  • Tandem Diabetes Care made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2776 holding.
  • GAMMA Investing first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Tandem Diabetes Care position peaked at $212K in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.